Skip to main content

Table 1 Hospital days and expenditures for illegal drug treatment (general, mental health and specialty hospitals), for 15 EU countries, 2010

From: Public spending for illegal drug and alcohol treatment in hospitals: an EU cross-country comparison

Country*

Public expenditure per hospital day (euros)

Hospital days for illegal drug treatment per 1,000 capita

Proportion of hospital days attributable to illegal drug treatment (%)

Illegal drug treatment expenditure by hospitals (million euros)

Illegal drug treatment expenditure by hospitals, per capita (euros)

Illegal drug treatment expenditure by hospitals, as percentage of GDP

Sweden

1532

9

0.88%

123

13.2

0.035%

Austria†

507

15

0.62%

65

7.8

0.023%

Germany

391

16

0.72%

523

6.4

0.021%

Slovenia

432

7

0.59%

6

3.2

0.018%

Finland†

428

6

0.28%

14

2.5

0.008%

Slovakia

165

11

0.75%

9

1.7

0.014%

Poland

167

9

0.70%

55

1.4

0.015%

Czech Republic

211

17

0.79%

37

3.5

0.025%

Portugal

1045

0.6‡

0.11%

6

0.6

0.004%

Hungary

121

5

0.28%

6

0.6

0.006%

Latvia†

140

3

0.24%

0.8

0.4

0.005%

Bulgaria

69

3

0.19%

2

0.2

0.004%

Lithuania

113

1

0.06%

0.4

0.1

0.001%

Romania

81

1

0.07%

2

0.1

0.002%

Cyprus†

936

0.01‡

0.002%

0.006

0.01

0.00003%

Mean k (SD)

423 (429)

7 (6)

0.42% (0.31%)

57 (133)

2.8 (3.7)

0.012% (0.01%)

  1. *The European countries are not classified in regions, because no global classification system is available for illegal drugs (contrary to studies on alcohol, which distinguish geographical areas by drinking traditions and patterns [44]). Drug-related research e.g., ([45, 46]) uses different types of classification according to the investigated type of drugs. Nevertheless, the conclusions for multiple countries are described by the UN geographical regions: Eastern Europe, Northern Europe, Southern Europe and Western Europe.
  2. †Contrary to the other countries, the live-born infants (Z38) of Austria, Cyprus, Latvia and Finland are not included in the total hospital days, and this could lead to an overestimation of the hospital expenditures.
  3. ‡The data for Cyprus cover only public sector hospitals. Portugal covers all public inpatient institutions and only two private hospitals. Consequently, the hospital days for illegal drug treatment are underestimated, and this may affect the proportion of hospital days attributable to illegal drug treatment. Therefore, the hospital days and public expenditures for illegal drug treatment in Cyprus and Portugal will not be further analyzed.